HCM
BEAT

Highlander Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Highlander Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,000
Closed -$12K – 841
2015
Q4 		$12K Sell
1,000
-14,000
-93% -$177K 0.01% 619
2015
Q3 		$183K Buy
15,000
+4,500
+43% +$57.4K 0.17% 153
2015
Q2 		$99K Buy
+10,500
New +$97.2K 0.09% 250

Other funds holding BEAT

CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Highlander Capital Management's BEAT Position: Q1 2016 in Review

Highlander Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2016, closing a stake of 1,000 shares — an estimated $12K sold.

Highlander Capital Management first reported a position in BEAT in Q2 2015 and held it in 3 quarters. The position peaked at $183K in Q3 2015. 112 funds tracked by Wall St. Rank hold BEAT as of Q1 2016.

  • Highlander Capital Management reported no remaining BioTelemetry, Inc. position as of Q1 2016 after selling out during the quarter.
  • Highlander Capital Management sold 1,000 BioTelemetry, Inc. shares in Q1 2016, an estimated $12K.
  • Highlander Capital Management first reported a position in BioTelemetry, Inc. in Q2 2015 and held it in 3 quarters.
  • Highlander Capital Management's BioTelemetry, Inc. position peaked at $183K in Q3 2015.
  • 112 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2016.

Based on Highlander Capital Management's 13F filing for Q1 2016, filed 11 May 2016.